Charles Theuer
Vorstandsvorsitzender bei TRACON PHARMACEUTICALS, INC.
Vermögen: 803 641 $ am 30.04.2024
Aktive Positionen von Charles Theuer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.07.2006 | - |
| Vorstandsvorsitzender | 02.08.2006 | - | |
| Investor Relations Kontakt | 01.07.2006 | - | |
| Präsident | 02.08.2006 | - | |
| Comptroller/Controller/Auditor | 15.06.2018 | 18.09.2019 | |
| Finanzdirektor/CFO | 15.06.2018 | 29.01.2021 | |
| 4D MOLECULAR THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.01.2016 | - |
| Independent Dir/Board Member | 01.01.2016 | - | |
| ONCTERNAL THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2018 | - |
| Independent Dir/Board Member | 01.05.2018 | - |
Karriereverlauf von Charles Theuer
Ehemalige bekannte Positionen von Charles Theuer
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2006 |
| PFIZER, INC. | Corporate Officer/Principal | 01.01.2003 | 01.01.2004 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01.01.1991 | 01.01.1993 |
| University of California, Irvine | Corporate Officer/Principal | - | - |
Ausbildung von Charles Theuer
| The University of California, San Francisco | Doctorate Degree |
| University of California, Irvine | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 10 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Börse
- Insiders
- Charles Theuer
- Erfahrung
